Prevalence of Occult Hepatitis C Virus in Egyptian Patients with Chronic Lymphoproliferative Disorders

Table 2

Laboratory data of patients and controls groups.

	Patients (𝑁=50)		Controls (𝑁=50)		𝑃 value
	Range	Mean ± SD	Range	Mean ± SD
Hemoglobin (gm%)	6.5–16	10.6 ± 2.5	11.4–16	13.3 ± 1.4	<0.0001***
Platelet count ×10^3 mm³	21–567	172.7 ± 104.8	168–394	282.5 ± 63.5	<0.0001***
Total leucocytic count/mm³	1.2–33	8.6 ± 5.6	6–15	10.0 ± 2.4	0.1074*
AST (IU/dL)	11–192	41.9±38.0	10–38	15.7 ± 2.1	<0.0001***
ALT (IU/dL)	7–133	34.1±29.9	12–48	18 ± 3.4	<0.0001***
Bilirubin (mg/dL)	0.10–2.80	0.75±0.64	0.1–1.1	0.8 ± 0.2	0.5992*

𝑁: number of subjects. *Not significant (NS) (𝑃 value > 0.05), **significant (S) (𝑃 value < 0.05), ***highly significant (HS) (𝑃 value < 0.0001).